S4/S20 and loss modulus (G") at 32ºC. Both viscoelastic moduli are defined as follows: G'= 0 / 0 cos  and G''=  0 / 0 sin  (where  0 and  0 are the amplitudes of stress and strain, and  is the phase shift between them).
The software Haake RheoWin®Job Manager V.3.3 and RheoWin®Data Manager V. 3 
.3 (Thermo Electron
Corporation, Karlsruhe, Germany) were used to carry out the test and analysis of the obtained data, respectively.
Drug incorporation into gel fibres
Incorporation of drug into the gel 1·2Br was quantified by 1 H NMR spectroscopy using a Varian 400 MHz NMR spectrometer from the Centres Científics I Tecnològics de la Universitat de Barcelona (CCiT-UB). 32 scans were recorded in every measurement.
For quantifying the incorporation of drug inside the gel fibres, gels from 1·2Br incorporating drug at a molar ration of 1:1 were formed inside the NMR tube, and the drug signals in spectra were compared to those from a drug solution at the same concentration. Peaks of the aromatic moeity from the drug were taken as the reference signal.
For instance, two aliquots containing (8.28 μmol) of AEBSF·HCl each were dissolved in 0.75 mL of deuterium oxide and 1 H NMR spectra of both (Tubes A and B) were recorded (Record 1). After that, 0.75 mL of deuterated methanol was added to tube A and 7.5 mg (8.28 μmol) of 1·2Br dissolved in 0.75 mL of deuterated methanol was added to tube B. Both tubes were shaken to promote mixing and the gel formation in tube B was observed, while tube A remained in solution. 1 H NMR spectra of both tubes were recorded in the same conditions (Record 2).
Microscopy: SEM/EDX
In all cases, xerogel samples were prepared by completely evaporating the solvent from freshly and two-week old gels.
Scanning Electron Microscopy (SEM) images and EDX analyses were acquired by the Electron Microscopy Service in the Institut de Ciència de Materials de Barcelona -Consejo Superior de Investigaciones Científicas (ICMAB-CSIC) on a QUANTA FEI 200 FEG-ESEM system on samples deposited on carbon tape, dried with N2 .and coated with a layer of gold.
Calorimetric studies
We have used this technique to evaluate the influence that the incorporation of AEBSF·HCl in gel 1·AEBSF has on the temperature and time of gelation, as well as on the changes in thermodynamic parameters such as enthalpy and entropy, as compared to gel 1·2Br. The strategy consists on introducing the freshly prepared mixture of the gelator, the solvents, and AEBSF·HCl if it is the case, into the equipment above the gel's melting temperature.
After that, temperature is slowly decreased in order to form the gel inside the equipment, while continuously tracking heat changes. Note that thermograms are plotted in an increasing temperature scale, but experiments are performed by decreasing the temperature, for which plots should be read from right to left.
A Microcal VP-DSC from Mettler-Toledo was used for performing the gelation of compound 1·2Br. 0.5 mL of a mixture of compound 1·2Br with both ethanol and water was introduced in the equipment at 35 °C. The sample was then cooled down slowly at 1 °C/min, from 35 °C to 5 °C, in order to form a gel inside the equipment, while monitoring the specific heat capacity (C p ) during the cooling of the sample.
Release studies
Drug release experiments were performed to prove that gel 1·AEBSF can release AEBSF·HCl from the nanocomposite material, and to demonstrate that such profile will not limit the permeation of the drug when applied S5/S20 on human skin. Conditions such as the Franz cells used and the temperature bath at 32 ºC were adjusted to be similar than those in the skin permeation experiments. PBS was chosen as the receptor medium for complying SINK conditions. Drug release studies from the gels were performed in a Microette transdermal diffusion system (Microette plus-Hanson Research) following previously reported methodologies. [2, 3] Vertically assembled Franz-type diffusion cells (Crown Glass) (2.54 cm 2 diffusion area) were used. Dialysis membranes (Cellu·Sep T3 dialysis membrane, MWCO 12000 -14000 Da, MFPI, USA), previously hydrated in ethanol:water 7:3, were placed in the Franz-type diffusion cells. Receptor chamber contained 10 mM PBS pH 7.4 for the study of gels with AEBSF·HCl, complying with SINK conditions. [4] The dialysis membrane and the donor container were put onto the glass receptor chamber and the assembly was fixed with a joint. The Franz-type cells were connected to a controlled temperature circulating bath set to 32°C. Gels of 1·2Br were prepared at a drug concentration of 5 mg/mL. Known weights of gel were placed into the donor compartment onto the dialysis membranes and the donor compartment was sealed with plastic paraffin film to prevent solvent evaporation. Samples were taken at given time intervals, and every sample taken was replaced by equal volume of the receptor solution. Release experiments of gels were done in triplicate.
Concentrations of samples were determined by HPLC and cumulative amounts of released drug as a function of time were plotted. Kinetic parameters were calculated from the Mean values of three replicas, performing a nonlinear least-squares regression using GraphPad Prism® (version 3.00, GraphPad software, Inc., USA). Different models were tested: Higuchi's square root of time, Korsmeyer-Peppas, One Phase Exponential Assosiation (firstorder), Weibull's equation and Zero-order. The best model was chosen accordign to de R 2 value.
Skin permeation studies
The permeation assay was done with human skin from the abdominal region obtained during plastic surgery of a healthy, 40 year-old woman who gave written, informed consent to the use of this material for research purposes.
The protocol was similar to that followed in the drug release study, replacing the dialysis membranes with skin previously dermatomed at 0.4 mm thickness, and placed with the stratum corneum facing the donor compartment, according to the guidelines. [5, 6] Gel was applied on the donor compartment (408.3±52.7 mg of gel, 2.3±0.3 mg of drug) in contact with the epidermal side of the skin (n=5). The samples were taken at given time intervals for 24 hours. Concentrations were determined using HPLC and cumulative amounts of drug permeated were plotted.
Kinetic parameters were calculated from the Median and range values performing a linear least-squares regression in the linear zone of the plot, [7] using GraphPad Prism® (version 3.00, GraphPad software, Inc., USA).
Drug retained inside the skin
Drug extraction from the skin: At the end of the permeation study, extracted drug from the skin was evaluated following a protocol described elsewhere. [2] The skin was removed from the Franz cell, cleaned with gauze soaked in a 0.05% solution of sodium dodecyl sulfate and washed in distilled water accurately. The permeation area of the skin was then excised, punctured with a needle, weighed, and drug contained therein was extracted with 1 mL of the corresponding receptor medium during 20 min of sonication. The resulting solutions were measured by HPLC, yielding the amount of drug extracted from the skin expressed in (μg g -1 cm -2 ). Non-parametric Mann Whitney test statistical analyses were performed to compare drug retention from different formulations. [7] Drug recovery experiments: A piece of skin from the same patient as in permeation experiments was immersed in S6/S20 studies, and kept at 32°C for 27 hours. The skin piece was cleaned with gauze soaked in a 0.05% solution of sodium dodecyl sulfate and washed in distilled water accurately. Drug concentrations of both solutions "before immersion" and "after immersion" were determined using HPLC in order to know the amount of drug that can be retained within the skin. Skin pieces were punctured with a needle, and drug was extracted with 1 mL of the corresponding receptor solution using sonication, as performed in drug retention experiments. Concentrations of the drug extractions were determined using HPLC. The percentage of drug that can be recovered after being retained within skin was determined as follows:
Drug recovery (%) = drug extracted (µg) / drug retained (µg). 
SUPPORTING RESULTS

Influence of drug concentration on gelation
S9/S20
Drug incorporation studies
Identical amounts of drug (8.28 μmol) were dissolved in deuterium oxide (0.75 mL) and put in two NMR tubes (A and B), and a spectrum of both was recorded (Record 1). Later on, a solution of gelator compound 1·2Br (8.28 μmol) in deuterated methanol (0.75 mL) was added to tube B while the same volume of solvent without compound was added to tube A. Tubes were shaken, resulting in gel formation in tube B but not in tube A. The final concentration of 1·2Br in tube B was 5 mg/mL. A spectrum of both tubes was recorded again (Record 2) and the intensity of the drug signals between Records 1 and 2 was compared. In both tubes, a decrease in the intensity of drug signals is expected in Record 2 when compared to Record 1 mainly due to the dilution generated by the addition of solvent. However, in tube B the decrease is higher because of some drug incorporation inside the fibres. Temperature ( o C) Figure S8 . Thermograms of gel 1·AEBSF formation. Different cycles were performed to prove thermoreversibility. S15/S20
Drug release
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